Navigation Links
Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.
Date:7/27/2009

Oldsmar, Fla., July 27 /PRNewswire-FirstCall/ --Cryo-Cell International, Inc. (OTC Bulletin Board: CCEL), one of the largest and most established leaders in stem cell innovation today announced a research and development collaboration agreement with Cryopraxis Cryobiology Ltd., a Brazilian-based global regenerative technology leader and stem cell research company. The partnership will allow Cryopraxis to conduct clinical studies using Cryo-Cell's proprietary C'elle(SM) menstrual stem technology (MenSCs) to identify potential future diagnostic and therapeutic uses in endometriosis and stress urinary incontinence in women.

Endometriosis is a painful condition that affects approximately five million American women. The condition is caused when the lining of the uterus grows outside of the uterus, resulting in scar tissue that causes severe pelvic pain and may lead to infertility. Endometriosis is commonly diagnosed through laparoscopic procedures that are painful and invasive. Additionally, women often face an unusually long delay from the onset of their symptoms to diagnosis, with an average delay of ten years.

This partnership will support an exciting new area of research that will investigate potential benefits of a new and non-invasive way to test for endometriosis. The possible diagnostic test will be based on analyses of the menstrual blood stem cells, which will be collected using Cryo-Cell's proprietary C'elle system.

"This research will determine if the stem cells found in menstrual blood can accurately provide a diagnosis that is highly precise, and this approach would offer women the added benefit of being both non-invasive and cost-effective," stated Eduardo Cruz, founder & CEO of Cryopraxis Cryobiology Ltd. "Additionally, this new method would potentially allow for earlier diagnosis of the disease, and subsequently enable women
'/>"/>

SOURCE Cryo-Cell International, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. NeurogesX Announces Preliminary Results of FDA-Requested Qutenza(TM) Study
2. Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
3. Cardica Announces Publication of Pivotal PAS-Port(R) Proximal Anastomosis System Clinical Trial Results
4. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
5. AlphaVax Announces Results from Initial Testing of Its H1N1 (Swine) Influenza Vaccine
6. Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences
7. Oncolytics Biotech(R) Inc. Announces Publication of Research on Synergistic Activity of Reovirus and Chemotherapy in NSCLC
8. Elbit Imaging Ltd. Announces - Swiss Team Uses InSightecs ExAblate(R) 4000 Brain System to Treat Patients With Functional Brain Disorders
9. Sirius Genomics Announces New Collaboration with Assistance Publique-Hopitaux de Paris
10. Relievant Medsystems Announces Completion of $20 Million Financing
11. Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... -- MarketReportsOnline.com announces addition of new market research ... Edition Material and Clinical Trial Requirements of Application ... of Registration Application for Imported Traditional Chinese Medicines ... The traditional medicines in Orient, especially, ... occidental as mysterious medicines. Until today not only ...
(Date:5/22/2013)... SAN FRANCISCO, Calif. , May 22, 2013 /PRNewswire/ ... today announced the clinical advancement of three programs in ... formulation of a JAK/SYK inhibitor, R348, being developed by ... other two programs are aimed at oncology targets and ... kinase inhibitor under development by BerGenBio AS (BerGenBio) and ...
(Date:5/22/2013)... , May 22, 2013 PRNewswire ... the production of a vaccine candidate for the ... third party laboratory using the iBioLaunch™ platform. This ... measured from initial antigen sequence information to purification ... http://photos.prnewswire.com/prnh/20120419/NY91086LOGO ) The iBioLaunch platform ...
Breaking Medicine Technology:China Pharmaceutical Market Guidebook Series (4) 2013 Report 2China Pharmaceutical Market Guidebook Series (4) 2013 Report 3China Pharmaceutical Market Guidebook Series (4) 2013 Report 4China Pharmaceutical Market Guidebook Series (4) 2013 Report 5Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 2Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 3Rigel's R348 to Initiate Phase 2 Clinical Trial in Dry Eye 4iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza 2
... RGEN ) announced today that the Company ... the use of RG1068, synthetic human secretin, to,improve ... resonance,imaging (MRI). This Phase 3 study is a ... patients will receive an,unenhanced MRI followed by a ...
... Type 2 Diabetes -, HAYWARD, Calif., March ... the discovery and development of,proprietary new medicines for ... has dosed the first cohort of healthy subjects ... potential first-in-class treatment,for type 2 diabetes., The ...
Cached Medicine Technology:Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 2Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 3Repligen Initiates Phase 3 Clinical Trial of RG1068 for Pancreatic MRI Imaging 4Metabolex Initiates Phase 1 Trial of MBX-2982 2
(Date:5/22/2013)... City, NJ (PRWEB) May 22, 2013 ... compliance, and management solutions for social enterprise collaboration ... LLC, a consulting firm based in Chicago, Ill. ... integrate their products and provide best-in-class solutions for ... and improve collaboration. , AvePoint’s DocAve Software ...
(Date:5/22/2013)... 22, 2013 BroadConnect Telecom, the ... IT security solutions in North America announced plans ... its newest BroadConnect hosted security solutions. Available on ... combination, BroadConnect’s new Security as a Service (SaaS) ... Internet connection of their choice, while optimizing internal ...
(Date:5/22/2013)... May 22, 2013 Asthma, a disorder ... and swell causes wheezing, shortness of breath, chest tightness ... occurs, the muscles surrounding the airways become tight and ... amount of air that can pass. Asthma attacks can ... airflow is severely restricted. Reuters reports that ...
(Date:5/22/2013)... May 22, 2013 Many people across ... for education on how to lose weight safely and ... challenging and may demotivate people to continue their journey ... discussed this week on Medical News Today ... to lose weight and actually losing those initial pounds ...
(Date:5/22/2013)... Poor adherence to appropriate medication therapy has been ... death (some 125,000 deaths in the U.S. every year ... It’s been estimated that between 33% and 69% of ... adherence — a reality that costs the American health-care ... is the degree of medication non-adherence — and the ...
Breaking Medicine News(10 mins):Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 2Health News:AvePoint Teams with Tahoe Partners, LLC to Enrich Microsoft SharePoint Deployments and Improve Collaboration 3Health News:BroadConnect Telecom to Launch Enterprise-Grade Hosted Security Solutions Engineered to Meet the Demands of Real World Business 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announce New hCG Diet Plans That May Reduce the Severity of Asthma Attacks 3Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Break the Cycle of Obesity and Weight Gain With New Education For Patients on How to Lose Weight the Healthy Way 3Health News:Patient Prompt® Announces New Drug Adherence Program to Assist in Prescribed Medication Compliance 2
... odds of disease, study shows, , WEDNESDAY, Sept. 16 ... replacement therapy women take to relieve menopausal symptoms seem ... face, a new French study suggests. , Overall, ... the risk of breast cancer, even when only used ...
... , GREENWOOD VILLAGE, Colo., Sept. ... cycle solutions for the healthcare industry, announced today that ... for Information Exchange (CORE(R)) Phase I Vendor Product Certification ... successfully completed certification testing - a process ensuring that ...
... , NEW YORK, Sept. 16 ... contract, will provide diagnostic imaging services to its nearly 16,000 ... a leading radiology benefit management (RBM) company. , , ... Vice President of Network Planning and Development, said "Elderplan members ...
... , RESEARCH TRIANGLE PARK, N.C., Sept. 16 ... making free medicines easier to obtain for patients who are unemployed, ... GSK is improving access to its patient assistance program, Bridges ... a simple, one-page application or enrollment by telephone with the help ...
... Presented by Food & Wine and Travel + Leisure Magazines and Held ... , NEW YORK, Sept. 16 Food Network New ... is pleased to announce that participating chefs of this year,s Festival have ... Weight Watchers. This is part of Weight Watchers second annual national ...
... Sept. 16 Capital BlueCross announced today that it will ... fully-insured members and those with individual coverage during the upcoming ... coverage customized to include this benefit. , , ... public in October. Various clinical vaccine trials have begun, some ...
Cached Medicine News:Health News:Timing, Type of HRT May Determine Breast Cancer Risk 2Health News:Timing, Type of HRT May Determine Breast Cancer Risk 3Health News:Recondo Technology Receives Certification From CAQH/Committee on Operating Rules for Information Exchange (CORE) 2Health News:Recondo Technology Receives Certification From CAQH/Committee on Operating Rules for Information Exchange (CORE) 3Health News:Elderplan Opts for Care to Care's Radiology Network 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 2Health News:GSK Makes it Easier for Unemployed, Uninsured to Get Free Medicines 3Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 2Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 3Health News:Chefs Participate in Weight Watchers National Lose For Good(TM) Campaign With 'Chefs Lose For Good' Initiative at the 2009 Food Network New York City Wine & Food Festival 4Health News:Capital BlueCross to Cover Administration Costs of H1N1 Vaccine for Fully-Insured Groups, Individuals This Flu Season 2
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
We offer small and large pre-gelled Surface Electrodes suitable for EGG or EMG recordings. Surface Electrodes, Skin Preparation and Conductive Cream complete the setup for a EGG study and are essenti...
Sandhill Scientific offers a comprehensive selection of solid state and water perfused catheters for both adult & pediatric applications.Contact Sandhill Scientific for full details...
Medicine Products: